Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
---|
01/22/2003 | EP1276725A2 5-substituted tetralones as inhibitors of ras farnesyl transferase |
01/22/2003 | EP1034159B1 Process for the preparation of acylated cyclic 1,3-dicarbonyl compounds |
01/22/2003 | CN1099407C Novel amino acid derivatives with improved multi-drug resistance activity |
01/21/2003 | US6509379 Variables are as disclosed herein, their salts, processes and intermediates for their preparation, and their use for controlling harmful fungi and animal pests. |
01/16/2003 | WO2003004512A1 Activators for oligonucleotide synthesis |
01/16/2003 | WO2003004493A1 Novel compounds, their preparation and use |
01/16/2003 | WO2003004467A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
01/16/2003 | WO2003004027A1 Substituted anilinic piperidines as mch selective antagonists |
01/16/2003 | WO2003004023A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
01/16/2003 | US20030013708 Therapeutic heterocyclic compounds |
01/16/2003 | US20030013704 Adamantane derivatives |
01/16/2003 | CA2454613A1 Substituted anilinic piperidines as mch selective antagonists |
01/16/2003 | CA2452609A1 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
01/16/2003 | CA2448913A1 Sulfone containing bicyclic aromatic ring compounds, their preparation and use as nicotinic acetyl-chloine receptors |
01/15/2003 | EP0974584B1 Fused ring compounds, process for producing the same and use thereof |
01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
01/14/2003 | US6506901 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma |
01/14/2003 | CA2217516C Triazole antifungal agent |
01/13/2003 | WO2002006237A1 Medicine comprising dicyanopyridine derivative |
01/13/2003 | CA2415899A1 Medicine comprising dicyanopyridine derivative |
01/09/2003 | WO2003002542A1 N-heterocyclic inhibitors of tnf-alpha expression |
01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
01/09/2003 | WO2003002518A1 Novel 2,4-difluorobenzamide derivatives as antiviral agents |
01/09/2003 | WO2003002498A1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives |
01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
01/09/2003 | US20030008879 For therapy of symptoms caused by withdrawal or partial withdrawal from the use of tobacco or of nicotine; for therapy of anxiety |
01/09/2003 | US20030008832 Method of inhibiting neoplastic cells with benzimidazole derivatives |
01/08/2003 | EP1272485A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides |
01/08/2003 | EP1272472A1 1h-pyrazole derivatives, method for the production thereof and their use for inhibiting and controlling nitrification |
01/08/2003 | CN1390206A Inhibitors of factor Xa |
01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
01/07/2003 | US6504033 Nitrogen compounds formed from stoichiometric amounts of formic acid and hydrazine; by product inhibition; purity |
01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
01/03/2003 | WO2003000664A1 Uracil derivatives and the use thereof for treating bacterial diseases |
01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
01/03/2003 | CA2451625A1 Substituted n-acyl-aniline derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
01/03/2003 | CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
01/02/2003 | EP1270571A1 Heterocyclic compounds, their production and use |
01/02/2003 | EP1270561A1 Brassinosteroid biosynthesis inhibitor |
01/02/2003 | EP1268471A1 N-heterocyclic derivatives as nos inhibitors |
01/02/2003 | EP1268455A2 Piperazine derivatives |
01/02/2003 | EP1268445A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
01/02/2003 | EP1268440A1 Imidazole carbenes |
01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
01/01/2003 | CN1388804A Amino acid-N-carboxy anhydrides having substitent at nitrogen |
01/01/2003 | CN1097592C Slfonic acid amide derivatives with herbicides activity |
12/31/2002 | US6500952 Processes for preparing aminophenylsulfonylureas, and intermediates therefor |
12/31/2002 | US6500817 Thiazolyl urea derivatives and their utilization as antiviral agents |
12/31/2002 | CA2094917C Herbicidal n-[(1,3,5-triazin-2-yl)-aminocarbonyl]-benzenesulfonamides |
12/27/2002 | WO2002074753A3 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
12/26/2002 | US20020198378 For therapy of retroviral infection, e.g., an HIV infection |
12/26/2002 | US20020198216 Novel farnesyl protein transferase inhibitors as antitumor agents |
12/25/2002 | CN1387529A N-substd. carbamoyloxyalkyl-azolium derivs. |
12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
12/25/2002 | CN1097052C Process for production of amidinoindole derivs, and salts thereof |
12/24/2002 | US6498253 Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
12/24/2002 | US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile |
12/24/2002 | US6497905 Aqueous solubility pharmaceutical formulations |
12/24/2002 | CA2252402C Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
12/19/2002 | WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
12/19/2002 | WO2002042248A3 Naphthalene derivatives |
12/19/2002 | US20020193614 Treatment of cardiovascular disorders |
12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
12/19/2002 | US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI |
12/19/2002 | US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands |
12/19/2002 | US20020193414 Adamantane derivatives |
12/19/2002 | US20020193411 Pesticidal 1-polyarylpyrazoles |
12/19/2002 | US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases |
12/19/2002 | US20020193398 For therapy and prophylaxis of blood coagulation and cardiovascular disorders |
12/19/2002 | US20020193382 Sulfonamide derivatives, their production and use |
12/19/2002 | DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them |
12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
12/18/2002 | EP1064273B1 1,3,4-thiadiazoles useful for the treatment of cmv infections |
12/17/2002 | US6495699 Antiarthritic agents; osteoporosis |
12/17/2002 | US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth |
12/17/2002 | US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
12/17/2002 | US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels |
12/17/2002 | US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome |
12/17/2002 | US6495270 Addition product of a heterocyclic amidine and a quinone is accelerator; encapsulation of electronic component parts; rapid curability, curability after moisture absorption under moist condition, pot life and flow properties |
12/12/2002 | WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
12/12/2002 | WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
12/12/2002 | WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |